Patients previously experiencing gastrointestinal symptoms from GLP-1 receptor agonists, including nausea, vomiting, or abdominal distension, have a greater risk of increased residual gastric contents and should be treated as if they had a full stomach, regardless of fasting
The "conversion charts" online are not real Search for "Wegovy to Zepbound conversion chart" and the results pages will give you a tidy-looking grid mapping each Wegovy dose to a Zepbound dose
Lilly filed lawsuits over this to for example Empower and Strive Pharmacy - who kept selling tirzepatide despite bans
Metabolic factors : Diabetes itself, dyslipidaemia, and metabolic syndrome are independent risk factors for gallbladder disease
The most widely prescribed GLP-1 for weight loss
licorice (Dipotassium Glycyrrhizate) soothes irritation and adds additional brightening